Detalhe da pesquisa
1.
Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines.
Vaccine
; 42(2): 383-395, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061956
2.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women.
Vaccine
; 41(31): 4541-4553, 2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37330371
3.
Multi-valent pneumococcal conjugate vaccine for global health: From problem to platform to production.
Hum Vaccin Immunother
; 18(4): 2117949, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239596
4.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Vaccine
; 40(15): 2352-2361, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789403
5.
Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Lancet Infect Dis
; 21(6): 834-846, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516293